RIVERSIDE SURGERY
525 NEW CHESTER ROAD, BIRKENHEAD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 8 | 100.0% | |
| HF 4 | 2011 | 8 | 11 | 72.7% | |
| HF 4 | 2012 | 6 | 7 | 85.7% | |
| HF 4 | 2013 | 11 | 13 | 84.6% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 2 | 2 | 100.0% | |
| HF004 | 2016 | 3 | 3 | 100.0% | |
| HF004 | 2017 | 10 | 11 | 90.9% | |
| HF004 | 2018 | 19 | 19 | 100.0% | |
| HF004 | 2019 | 32 | 33 | 97.0% | |
| HF004 | 2020 | 31 | 34 | 91.2% | |
| HF006 | 2021 | 84 | 95 | 88.4% | |
| HF006 | 2022 | 88 | 91 | 96.7% | |
| HF006 | 2023 | 86 | 87 | 98.9% |
